Examination of Physiotherapists' Knowledge, Awareness and Competence on Physical Activity and Exercise in Hemophilia Patients
Launched by GULHANE SCHOOL OF MEDICINE · Mar 13, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how well physiotherapists understand and feel prepared to help people with hemophilia stay active through exercise and physical activity. Hemophilia is a condition that affects blood clotting, which can make physical activity more challenging for those who have it. By examining physiotherapists’ knowledge, awareness, and the training they’ve received, the study aims to identify ways to better support them in helping hemophilia patients manage their health through exercise.
To participate in this study, you would need to be a licensed physiotherapist. The trial is currently recruiting participants and does not have an age or gender restriction, meaning all physiotherapists are welcome to take part. If you join, you can expect to share your experiences and views on your education and the challenges you face in promoting exercise for hemophilia patients. The insights gained from this study will help improve the training and resources available to physiotherapists, ultimately benefiting those living with hemophilia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Profession Group: Participants must be physiotherapists.
- Exclusion Criteria:
- • Non-Physiotherapists: Individuals who are not licensed physiotherapists will be excluded from the study.
About Gulhane School Of Medicine
Gulhane School of Medicine is a prestigious medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the school fosters a collaborative environment where multidisciplinary teams work to explore new treatment modalities and enhance medical knowledge. By engaging in rigorous clinical research, Gulhane School of Medicine aims to contribute to the development of effective therapies and improve health outcomes, ultimately benefitting both the local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Keçiören, Turkey
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported